Suppr超能文献

人肺表面活性物质蛋白A和D与螨(屋尘螨)过敏原的相互作用。

Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens.

作者信息

Wang J Y, Kishore U, Lim B L, Strong P, Reid K B

机构信息

Department of Biochemistry, University of Oxford, UK.

出版信息

Clin Exp Immunol. 1996 Nov;106(2):367-73. doi: 10.1046/j.1365-2249.1996.d01-838.x.

Abstract

Human lung surfactant proteins A (SP-A) and D (SP-D) are both collagenous C-type lectins which appear to mediate antimicrobial activity by binding to carbohydrates on micro-organisms and to receptors on phagocytic cells. Purified native SP-A and SP-D, isolated from human bronchoalveolar lavage fluid, were found to bind to whole mite extracts (Dermatophagoides pteronyssinus) and the purified allergen Der p I, in a carbohydrate-specific and calcium-dependent manner. Binding was inhibited by ethylenediamine tetra-acetic acid (EDTA) as well as by maltose in the case of SP-D, or mannose in the case of SP-A. A recombinant polypeptide, which trimerized to form the neck region and carbohydrate recognition domains of SP-D, also inhibited the binding of native SP-D to the whole mite extract and Der p I. Both SP-A and SP-D did not bind to deglycosylated whole mite extracts or to recombinant Der p proteins, which lacked carbohydrate residues. These results suggest that the ability of surfactant proteins to bind certain allergens is mediated through their carbohydrate-recognition domains (CRDs) interacting with carbohydrate residues on the allergens. Moreover, SP-A and SP-D were found to inhibit allergen-specific IgE binding to the mite extracts either via steric hindrance or competitive binding. It is therefore possible that SP-A and SP-D may be involved in the modulation of allergen sensitization and/or the development of allergic reactions.

摘要

人肺表面活性物质蛋白A(SP-A)和蛋白D(SP-D)均为胶原性C型凝集素,它们似乎通过与微生物上的碳水化合物以及吞噬细胞上的受体结合来介导抗菌活性。从人支气管肺泡灌洗液中分离出的纯化天然SP-A和SP-D,被发现以碳水化合物特异性和钙依赖性方式与全螨提取物(屋尘螨)和纯化的变应原Der p I结合。对于SP-D,乙二胺四乙酸(EDTA)以及麦芽糖可抑制结合;对于SP-A,甘露糖可抑制结合。一种三聚化形成SP-D颈部区域和碳水化合物识别结构域的重组多肽,也抑制天然SP-D与全螨提取物和Der p I的结合。SP-A和SP-D均不与去糖基化的全螨提取物或缺乏碳水化合物残基的重组Der p蛋白结合。这些结果表明,表面活性物质蛋白与某些变应原结合的能力是通过其碳水化合物识别结构域(CRD)与变应原上的碳水化合物残基相互作用来介导。此外,发现SP-A和SP-D可通过空间位阻或竞争性结合来抑制变应原特异性IgE与螨提取物的结合。因此,SP-A和SP-D可能参与变应原致敏的调节和/或过敏反应的发生。

相似文献

引用本文的文献

3
Allergic Rhinitis: A Clinical and Pathophysiological Overview.变应性鼻炎:临床与病理生理学概述
Front Med (Lausanne). 2022 Apr 7;9:874114. doi: 10.3389/fmed.2022.874114. eCollection 2022.
4
Pulmonary Surfactants: a New Therapeutic Target in Asthma.肺表面活性剂:哮喘治疗的新靶点。
Curr Allergy Asthma Rep. 2020 Sep 11;20(11):70. doi: 10.1007/s11882-020-00968-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验